HIGHLIGHTS
- who: Polina Pyatilova from the Kyoto Pharmaceutical University, Japan have published the Article: The Number of MRGPRX2-Expressing Cells Is Increased in Skin Lesions of Patients With Indolent Systemic Mastocytosis, But Is Not Linked to Symptom Severity, in the Journal: (JOURNAL)
- what: Frontiers in Immunology | www.frontiersin.org Increased Numbers of MRGPRX2+ Cells, MRGPRX2-mRNA+ MCs, and CST+ and MBP+ Cells are Not Associated With Clinical and Laboratory Features of ISM Finally, the authors aimed to assess the association of MRGPRX2+ cells, MRGPRX2-mRNA+ MCs, and CST+ and MBP+ cells in the skin with clinical . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.